Is There an Inherent Limit to the Efficacy of Calcitonin Gene-Related Peptide Receptor Antagonists in the Acute Treatment of Migraine? A Comment

Journal of Headache and Pain - Italy
doi 10.1007/s10194-009-0157-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Is There an Inherent Limit to Acute Migraine Treatment Efficacy?

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2009English

Triptans and Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists

Clinical Neurology
Neurology
2012English

Calcitonin Gene-Related Peptide (CGRP) and Migraine

Headache
Neurology
2006English

Role of Calcitonin Gene Related Peptide in Development of Mab in Migraine: A Review

International Research Journal Of Pharmacy
2019English

Calcitonin Gene Related Peptide (CGRP) in Pain and Migraine: A Mini-Review

Endocrinology&Metabolism International Journal
2018English

The Calcitonin/Calcitonin Gene-Related Peptide Family in Invertebrate Deuterostomes

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Development of a Novel Antibody to Calcitonin Gene-Related Peptide for the Treatment of Osteoarthritis-Related Pain

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2014English

Calcitonin Gene-Related Peptide: An Update on the Biology

Current Opinion in Neurology
Neurology
2009English

Calcitonin-Gene-Related Peptide

Inpharma Weekly
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy